Um dos principais objetivos do Life4me+ - é prevenir novos casos de HIV e outras ISTs, hepatite C e tuberculose.

O aplicativo ajuda a estabelecer uma comunicação anônima entre médicos e pessoas soropositivas. A App permite que você organize convenientemente o seu horário de toma dos medicamentos e defina de uma forma personalizada os lembretes.

Todas as notícias / Março 2020

Arquivo

✕

31 março 2020

6149

IAS launches HIV & COVID-19 webinar series

IAS launches HIV & COVID-19 webinar series

Responding to the global COVID-19 crisis the International AIDS Society (IAS) is organising a series of webinars to address COVID-19 and its impact on people living with HIV around the world. The webinars are intended to provide access to, and discussion of, the latest ...

28 março 2020

6671

Abbott launches new point of care Coronavirus test with results in five minutes

Abbott launches new point of care Coronavirus test with results in five minutes

The US Food and Drug Administration (FDA) has approved a new point of care test from Abbott that can provide a SARS-CoV-2 result in as little as five minutes. The molecular test runs on Abbott's established ID NOW platform which can be used in a clinical setting or, thanks ...

28 março 2020

5072

HIV conferences cancelled amid global pandemic

HIV conferences cancelled amid global pandemic

Three HIV conferences due to take place this Spring/Summer have been cancelled as the Coronavirus pandemic continues to wreak havoc around the world. Both the International AIDS Society (IAS) AIDS 2020 conference in San Francisco, scheduled for July, and the HIV 2020 ...

27 março 2020

5750

Gilead withdraws their Orphan Drug Status application for hope COVID-19 treatment, Remdesivir.

Gilead withdraws their Orphan Drug Status application for hope COVID-19 treatment, Remdesivir.

As we reported earlier this week the US Food & Drug Administration (FDA) granted Gilead Sciences' application to grant their antiviral treatment, Remdesivir, Orphan Drug Status. Yesterday, however, Gilead Sciences asked the FDA to revoke the special status after facing ...

24 março 2020

5778

Special status given to COVID-19 drug, Remdesivir, causes cost and supply concerns

Special status given to COVID-19 drug, Remdesivir, causes cost and supply concerns

The US Food and Drug Administration (FDA) has granted Gilead Sciences "orphan" drug status for their antiviral drug, Remdesivir, causing concern over what this means for access and pricing for the promising COVID-19 treatment. The "orphan" drug designation is intended ...

24 março 2020

5684

World Health Organisation launches large trial into COVID-19 treatments

World Health Organisation launches large trial into COVID-19 treatments

The World Health Organisation (WHO) has launched a huge trial, called SOLIDARITY, to assess the efficacy of four different treatments against SARS-CoV-2 (the Coronavirus) and COVID-19. The four treatments that the WHO will be studying are: 1. Remdesivir (an experimental ...

16 março 2020

6593

Urgent call to patients on Kaletra

Urgent call to patients on Kaletra

Kaletra is urgently needed to treat patients infected with the coronavirus (COVID19). The clinics don't have enough supplies. Please bring back to the clinic all the Kaletra you have in stock immediately and have your HIV therapy changed. If a therapy switch is not possible, ...

13 março 2020

6542

CROI 2020: COVID-19 Special Session

CROI 2020: COVID-19 Special Session

Last Tuesday, March 10, at a conference in the United States on retroviruses and opportunistic infections (CROI 2020), a special session was held on the novel coronavirus and the condition known as COVID-19. Four reports were presented on key aspects of the epidemiology ...

13 março 2020

13978

People living with HIV at no greater risk of COVID-19, than general population

People living with HIV at no greater risk of COVID-19, than general population

There is no evidence that people living with HIV are at greater risk of COVID-19, or more severe disease if affected, than the general population. That’s the message from the British HIV Association (BHIVA) who released updated guidance on the matter today. Data presented ...

12 março 2020

4971

Levels of HIV fall in Australia thanks to Treatment As Prevention (TASP)

Levels of HIV fall in Australia thanks to Treatment As Prevention (TASP)

Data presented at CROI 2020, this week, has shown the impacts of Treatment as Prevention (TASP) on both new HIV diagnoses and community viremia (the number of people living with transmittable levels of HIV) in Australia. The study showed a significant decrease in active ...

1 2